44
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22424 |
1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(4-cyanophenoxy)phenyl)urea
|
Apoptosis; STAT | Apoptosis; JAK/STAT signaling; Stem Cells |
SC-1 是一种 Sorafenib 的衍生物,可抑制 STAT3磷酸化,通过依赖 SHP-1 的 STAT3失活诱导细胞凋亡,具有抗癌作用。 | |||
T5994 |
KPT-6566
2-[[4-[[[4-(叔丁基)苯基]磺酰基]亚氨基]-1-氧代-1,4-二氢-2-萘基]硫基]乙酸 |
Others | Others |
KPT-6566 是共价结合的脯氨酰异构酶PIN1选择性抑制剂,能够与 PIN1 的催化位点共价结合,抑制并降解PIN1,具有抗癌活性。它对PIN1 PPIase 结构域的IC50=640 nM,Ki=625.2 nM。 | |||
T2378 |
RGB-286638 free base
|
GSK-3; MEK; JAK; CDK | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; JAK/STAT signaling; MAPK; PI3K/Akt/mTOR signaling; Stem Cells |
RGB-286638 free base 是一种新型 CDK 抑制剂,抑制cyclin T1-CDK9、cyclin B1-CDK1、cyclin E-CDK2、cyclin D1-CDK4、cyclin E-CDK3和p35-CDK5活性,IC50分别为 1、2、3、4、5 和 5 nM。它也抑制 GSK-3β、TAK1、Jak2 和 MEK1,IC50值分别为 3、5、50和 54 nM。 | |||
T15335 |
FN-1501
|
FLT; CDK | Angiogenesis; Cell Cycle/Checkpoint; Tyrosine Kinase/Adaptors |
FN-1501 是一种有效的 FLT3 和 CDK 抑制剂,具有抗肿瘤的活性,对 CDK2/cyclin A、CDK4/cyclin D1、CDK6/cyclin D1 和 FLT3 的 IC50值分别为 2.47、0.85、1.96 和 0.28 nM。 | |||
T2059 |
Purvalanol A
NG-60 |
Apoptosis; CDK; Autophagy | Apoptosis; Autophagy; Cell Cycle/Checkpoint |
Purvalanol A (NG-60) 是一种CDK 抑制剂,对 cdc2-cyclin B、cdc2-cyclin B、cdk2-cyclin E、cdk4-cyclin D1 和 cdk5-p35 的IC50值分别为 4、70、35、850 和 75 nM。 | |||
T3207 |
Briciclib
ON 014185 |
CDK; PERK; Autophagy | Apoptosis; Autophagy; Cell Cycle/Checkpoint |
Briciclib (ON 014185) 是一种 ON 013100 衍生物,是一种抑制 Y 细胞中 cyclin D1 积累的小分子。它可靶作用于eIF4E,有抑制实体瘤的潜力。 | |||
T21720 |
GP-82996
Cdk4/6 Inhibitor IV,CINK4 |
CDK | Cell Cycle/Checkpoint |
GP-82996 (CINK4) (CINK4) 是 CDK4/6的药理学抑制剂。GP-82996 对 CDK4/cyclin D1、CDK6/cyclin D1 和 Cdk5/p35 的 IC50s 分别为 1.5、5.6 和 25 μM。GP-82996 诱导肿瘤细胞 U2OS 的凋亡,可用于癌症研究。 | |||
T60485 |
DIF-3
|
||
DIF-3 is a chemical compound that acts by activating GSK-3β to facilitate the degradation of cyclin D1 and c-Myc, resulting in reduced expression levels of these proteins. In addition, DIF-3 inhibits Wnt/β-catenin signaling pathway-related proteins in DLD-1 cells. This compound exerts a potent antiproliferative effect on the HeLa human cervical cancer cell line by inducing cyclin D1 degradation and inhibiting cyclin D1 mRNA expression [1]. | |||
T39957 |
CDK4/6-IN-6
|
CDK | Cell Cycle/Checkpoint |
CDK4/6-IN-6 是CDK4/CDK6的有效抑制剂,结合CDK4/Cyclin D1 和 CDK6/Cyclin D3 的 Ki 为 0.6 nM 和 13.9 nM。 | |||
T15137 |
DK419
|
Wnt/beta-catenin; AMPK | Chromatin/Epigenetic; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Stem Cells |
DK419 是一种具有口服活性的 Wnt/β-catenin 信号通路抑制剂,IC50 为 0.19 μM。 DK419 降低 Axin2、β-catenin、c-Myc、Cyclin D1 和 Survivin 的蛋白质水平。它还诱导 pAMPK 的产生。 | |||
T16391 |
ON-013100
|
CDK | Cell Cycle/Checkpoint |
ON-013100 是有丝分裂的抑制剂,具有抗肿瘤活性。ON-013100能够抑制细胞周期蛋白 D1 的表达。 | |||
T11826 |
LCH-7749944
GNF-PF-2356 |
Apoptosis; PAK | Apoptosis; Cytoskeletal Signaling |
LCH-7749944 (GNF-PF-2356) 是一种 PAK4抑制剂,IC50为 14.93 μM。它通过下调 PAK4/c-Src/EGFR/cyclin D1 途径有效抑制人胃癌细胞的增殖,并诱导凋亡。 | |||
T2615 |
Flavopiridol hydrochloride
Alvocidib Hydrochloride,NSC 649890,MDL 107826A,HL 275,FLAVOPIRIDOL HCL,NSC 649890 HCl |
HIV Protease; CDK; Autophagy | Autophagy; Cell Cycle/Checkpoint; Microbiology/Virology; Proteases/Proteasome |
Flavopiridol hydrochloride (MDL 107826A) 是一种CDK 的广谱抑制剂,与 ATP 竞争性地抑制 CDK1,CDK2 和 CDK4 的活性,IC50值分别为 30, 170, 100 nM。 | |||
T14665L |
Motixafortide TFA(664334-36-5,Free)
TF 14016 TFA,BKT140 TFA,BL-8040 TFA,T140 TFA |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
Motixafortide TFA(664334-36-5,Free) (BKT140 TFA) 是 CXCR4 的拮抗剂,IC50 为 ~1 nM。它通过改变 miR-15a/16-1 表达下调 ERK、BCL-2、MCL-1 和 cyclin-D1 来诱导 AML 原始细胞凋亡。 | |||
T3708 |
BP-1-102
|
STAT | JAK/STAT signaling; Stem Cells |
BP-1-102 是可口服的转录因子Stat3小分子抑制剂,IC50值为 6.8 μM。 | |||
T6312 |
R547
Ro 4584820 |
Apoptosis; GSK-3; PKA; CDK | Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
R547 (Ro 4584820) 是一种口服有效,选择性, ATP 竞争性CDK 抑制剂,对 CDK1/cyclin B、 CDK2/cyclin E 和 CDK4/cyclin D1 作用的Ki 值分别为 2 nM、3 nM、1 nM。 | |||
T6924 |
Riviciclib hydrochloride
P276-00 |
Apoptosis; CDK | Apoptosis; Cell Cycle/Checkpoint |
Riviciclib hydrochloride (P276-00) 是一种CDK 抑制剂,抑制CDK9-cyclinT1、CDK4-cyclin D1、CDK1-cyclinB 的IC50值分别为 20 nM、63 nM、79 nM。它对 Cisplatin 耐药性细胞具有抗肿瘤活性。 | |||
T2082 |
CDK4-IN-1
|
CDK | Cell Cycle/Checkpoint |
CDK4-IN-1 是一种新型的特异性 CDK4/Cyclin D1 抑制剂,IC50 为 10 nM;分别是 CDK1/Cyclin B (IC50>15 uM) 和 CDK2/Cyclin A (IC50=5.265 uM) 的 1500 倍和 500 倍。 | |||
T27804 |
LCAHA
|
||
LCAHA is a USP2a inhibitor. LCAHA inhibits growth of cyclin D1-dependent cells. | |||
T27128 |
DCB-3503
NSC716802,NSC 716802,NSC-716802,DCB3503,DCB 3503 |
||
Tylophorine analog DCB-3503 is a potential anticancer and immunosuppressive agent. DCB-3503 suppresses the translation of cellular regulatory proteins, including cyclin D1, at the elongation step. DCB-3503 allosterically regulates the ATPase and chaperone activities of HSC70 by promoting ATP hydrolysis in the presence of specific RNA binding motifs (AUUUA) of cyclin D1 mRNA. | |||
T63362 |
Ulecaciclib
|
||
Ulecaciclib 是口服具有活力的、能够透过血脑屏障的、表现出良好的药代动力学特征的细胞周期蛋白依赖激酶 (CDK) 抑制剂,对CDKs 的ki 为 0.62 μM (CDK2/Cyclin A)、3 nM (CDK6/Cyclin D3) 、0.2 nM (CDK4/Cyclin D1)和 0.63 μM (CDK7/Cyclin H)。 | |||
T39956 |
CDK4/6-IN-5
CDK4/6-IN-5 |
||
CDK4/6-IN-5 is a highly effective inhibitor of CDK4 and CDK6, with Ki values of 0.2 and 4.4 nM for CDK4/Cyclin D1 and CDK6/Cyclin D3, respectively (WO2019207463A1, example A93). | |||
T28266 |
Org-6906
Org6906,Org 6906,Org-6906 free |
||
Tylophorine analog Org-6906 is a potential anticancer and immunosuppressive agent. Org-6906 suppresses the translation of cellular regulatory proteins, including cyclin D1, at the elongation step. Org-6906 allosterically regulates the ATPase and chaperone activities of HSC70 by promoting ATP hydrolysis in the presence of specific RNA binding motifs (AUUUA) of cyclin D1 mRNA. | |||
T72829 | β-catenin-IN-4 | ||
β-catenin-IN-4 是一种β-catenin 抑制剂,Ki 值为 0.64 μM。β-catenin-IN-4 降低 cyclin D1 和c-Myc 的蛋白表达水平。 | |||
T12737 |
Riviciclib
P276-00 (free base) |
Others | Others |
Riviciclib is a potent inhibitor of cyclin-dependent kinase (CDK)(CDK9-cyclinT1, CDK4-cyclin D1, and CDK1-cyclinB with IC50s of 20 nM, 63 nM, and 79 nM, respectively),with antitumor activity on cisplatin-resistant cells. | |||
T11653 |
Indirubin-5-sulfonate
|
Others | Others |
Indirubin-5-sulfonate shows inhibitory activity against GSK-3β. Indirubin-5-sulfonate is a cyclin-dependent kinase (CDK) inhibitor, with IC50 values of 55 nM, 35 nM, 150 nM, 300 nM and 65 nM for CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK4/cyclin D1, | |||
TP2133 |
[Ala92]-p16 (84-103)
|
||
Peptide derived from the tumor suppressor protein p16; inhibits cyclin-dependent kinase-4 (cdk4)/cyclin D1 (IC50 ~ 1.5 μM) and binds to cdk6. | |||
T30807 |
CG0009
CG-0009,CG 0009 |
||
CG0009 is a potent and highly selective glycogen synthase kinase 3 (GSK3) inhibitor that inhibitions proliferation, induces apoptosis, and activates the p53-Bax pathway in breast cancer cells through cyclin D1 depletion. CG0009 inhibit breast cancer cell | |||
T38927 |
SR-1277
|
||
SR-1277 is a highly potent, selective, and ATP competitive inhibitor of CK1δ/ε, with IC50 values of 49 nM and 260 nM, respectively. Additionally, SR-1277 exhibits inhibitory effects on FLT3, CDK4/cyclin D1, CDK6/cyclin D3, and CDK9/cyclin K, with IC50 values of 305 nM, 1340 nM, 311 nM, and 109 nM, respectively. Taken together, SR-1277 represents a valuable tool for cancer research. | |||
T61266 | CA224 | ||
CA224 (Compound 1) 是一种选择性的、具有口服活性的Cdk4–cyclin D1抑制剂,IC50值为 6.2 μM。CA224 诱导细胞凋亡 (apoptosis),具有抗肿瘤活性。 | |||
T73196 |
RGB-286638
|
||
RGB-286638 是一种有效的 CDK 抑制剂,抑制cyclin T1-CDK9,cyclin B1-CDK1,cyclin E-CDK2,cyclin D1-CDK4,cyclin E-CDK3和p35-CDK5活性,IC50分别为 1,2,3,4,5 和 5 nM;同时可抑制GSK-3β,TAK1,Jak2和MEK1,IC50值分别为 3,5,50,和 54 nM。 | |||
T62192 |
CDK4/6-IN-9
|
||
CDK4/6-IN-9 (compound 10) 是一种 CDK4/6 的选择性抑制剂,能够作用于 CDK6/cyclin D1 (IC50: 905 nM)。CDK4/6-IN-9 对多发性骨髓瘤 (MM) 具有潜在的研究价值。 | |||
T82762 |
Cdc25A (80-93) (human)
|
||
Cdc25A (80-93) (human)为调控细胞周期蛋白D1及G1/S转换中相关蛋白表达,进而控制细胞增殖与肿瘤发生的多肽。该化合物在癌症研究中具应用价值。 | |||
T63982 |
Anticancer agent 50
|
||
Anticancer agent 50 (compound 6) 是 ABCB1 外排泵的有效调节剂,具有细胞毒活性和抗增殖活性。Anticancer agent 50 能够减少细胞周期蛋白 D1 的表达,并诱导 p53 表达。Anticancer agent 50 对 T 淋巴瘤表现出研究潜力。 | |||
T41278 | Obatoclax | ||
Obatoclax (GX15-070) 是一种 BH3 模拟物,是泛BCL-2家族蛋白抑制剂,对 BCL-2 的Ki 值为 220 nM。Obatoclax 诱导依赖自噬 (autophagy)的细胞死亡,并靶向细胞周期蛋白 D1 进行蛋白酶体降解。Obatoclax 具有抗癌和广谱抗寄生虫 (antiparasitic) 活性。 | |||
T83433 |
1D228
|
c-Met/HGFR | Tyrosine Kinase/Adaptors |
1D228为c-Met/TRK抑制剂,显示出抗肿瘤活性。该化合物通过抑制细胞周期蛋白D1,诱导G0/G1停滞,进而抑制癌细胞的增殖和迁移。该化合物适用于胃肿瘤、肝肿瘤和血管肿瘤研究领域。 | |||
T62514 |
HDAC-IN-46
|
||
HDAC-IN-46 (compound 12c) 是一种 HDAC 的有效抑制剂,能够作用于 HDAC1 (IC50: 0.21 μM) 和 HDAC6 (IC50: 0.021 μM)的。HDAC-IN-46 在 MDA-MB-231 细胞中可以上调 p-p38,下调 Bcl-xL 和 cyclin D1。HDAC-IN-46 能够将细胞周期阻滞在 G2 期,并诱导细胞凋亡 (apoptosis)。HDAC-IN-46 能够用于三阴性乳腺癌 (TNBC) 的研究。 | |||
T68980 | MRK003 | ||
MRK003 is a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma. MRK003 treatment induced caspase-dependent apoptosis and inhibited proliferation of MM and NHL cell lines and patient cells. Examination of signaling events after treatment showed time-dependent decrease in levels of the notch intracellular domain, Hes1 and c-Myc. MRK003 downregulated cyclin D1, Bcl-Xl and Xiap levels in NHL cells and p21, Bcl-2 and Bcl-Xl in MM cel... | |||
T70273 |
APTO-253 HCl
|
||
APTO-253, also known as LOR-253, LT-253, is a small molecule inhibitor of human metal-regulatory transcription factor 1 (MTF-1) with potential antitumor activity. MTF-1 inhibitor LOR-253 inhibits MTF-1 activity and thereby induces the expression of MTF-1 dependent tumor suppressor factor Kruppel like factor 4 (KLF4). This subsequently leads to the downregulation of cyclin D1, blocking cell cycle progression and proliferation. This agent also causes decreased expression of genes involved in tumor... | |||
T70706 |
APTO-253 isomer
|
||
APTO-253 isomer is an isomer of APTO-253 with the Fluoro-atom in 6-position. APTO-253 also known as LOR-253, LT-253, is a small molecule inhibitor of human metal-regulatory transcription factor 1 (MTF-1) with potential antitumor activity. MTF-1 inhibitor LOR-253 inhibits MTF-1 activity and thereby induces the expression of MTF-1 dependent tumor suppressor factor Kruppel like factor 4 (KLF4). This subsequently leads to the downregulation of cyclin D1, blocking cell cycle progression and prolifer... | |||
T72522 |
Aurora kinase-IN-1
|
||
Aurora kinase-IN-1 是aurora kinase 的有效抑制剂。Aurora kinase-IN-1 上调 G1 细胞周期抑制蛋白 (包括 p21 和 p27) 以及 G1 进行性细胞周期蛋白 D1 的表达,并下调 G1-to-S 进行性细胞周期蛋白,导致细胞周期停滞在 G1/S 边界。Aurora 激酶-IN-1 还诱导细胞凋亡 (apoptosis)。Aurora 激酶-IN-1 是化疗药物的先导化合物。 | |||
T29172 |
YD277
YD 277,YD-277 |
||
YD277 is a small molecule derived from ML264, a KLF5 inhibitor that elicits cytotoxic effects in colon cancer cell lines. YD277 significantly induced G1 cell cycle arrest and apoptosis in MDA-MB-231 and MDA-MB-468 TNBC cells, independent of KLF5 inhibitio | |||
T69221 |
BMS-554417
|
||
BMS-554417 is a novel inhibitor of IGF-IR, which inhibits IGF-IR and insulin receptor kinase activity and proliferation in vitro, and reduces tumor xenograft size in vivo. In a series of carcinoma cell lines, the IC50 for proliferation ranged from 120 nmol/L (Colo205) to >8.5 micromol/L (OV202). BMS-554417 treatment inhibited IGF-IR and insulin receptor signaling through extracellular signal-related kinase as well as the phosphoinositide 3-kinase/Akt pathway, as evidenced by decreased Akt phosph... | |||
T36844 |
Inostamycin A
|
||
Inostamycin A is a bacterial metabolite that has been found inStreptomycesand has anticancer activity.1It is an inhibitor of CDP-diacylglycerol:inositol 3-phosphatidyltransferase (IC50= 0.02 μg/ml in A431 cell membranes) and is selective for CDP-diacylglycerol:inositol 3-phosphatidyltransferase over phospholipase C (PLC) and phosphatidylinositol kinase at 10 μg/ml.2Inostamycin A decreases viability of YCU-T892, KCC-TC873, KB, HSC-4, and YCU-T891 oral squamous cell carcinoma (OSCC) cells in a con... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1637 |
Eurycomalactone
|
Anti-infection; NF-κB | Microbiology/Virology; NF-κB |
Eurycomalactone 是一种NF-κB 抑制剂,IC50=0.5 μM,是一种天然产物。它可抑制蛋白合成,降低 cyclin D1 蛋白水平,但对 TNFα 诱导的 IκBα 降解或 IKKα/β 和 IκBα 的磷酸化水平没有作用。 | |||
T6S1917 |
Schisandrol B
Gomisin A,TJN-101,Besigomsin,五味子醇乙,Gamma-Schisandrin,戈米辛A,Schizandrol B,Wuweizi alcohol-B |
P450; Reactive Oxygen Species; Autophagy | Autophagy; Immunology/Inflammation; Metabolism; NF-κB |
Schisandrol B (Besigomsin) 是华中五味子的主要活性成分,具有保肝、抗炎、抗糖尿病和抗氧化的作用。它抑制活性氧的产生,也抑制 P-糖蛋白和CYP3A 的活性。 | |||
TN1674 |
Garcinone D
伽升沃 D |
Reactive Oxygen Species; Nrf2; STAT | Immunology/Inflammation; JAK/STAT signaling; Metabolism; NF-κB; Stem Cells |
Garcinone D 是来自山竹的一种呫吨酮,可促进 C17.2 神经干细胞的增殖。它以浓度和时间依赖的方式增加磷酸化信号转导和转录激活因子 3 (p-STAT3)、Cyclin D1 和核因子红细胞 2 相关因子 (Nrf2)、以及血红素加氧酶-1 (HO-1) 的蛋白质水平。 | |||
T27305 |
Fascaplysin chloride
NSC622398,NSC 622398,Fascaplysin,NSC-622398 |
||
Fascaplysin is a cyclin D kinase 4/ cyclin D1 inhibitor (IC50 = 0.35 μM). Fascaplysin induces caspase mediated crosstalk between autophagy and apoptosis through the inhibition of PI3K/AKT/mTOR signaling cascade in human leukemia HL-60 cells. | |||
TN6198 |
Mahanine
|
||
Mahanine has effects on the activation of the apoptotic pathway in human leukemia U937 cells, causes the mitochondrial membranes to lose their permeability, resulting in caspase-3 activation and apoptosis. Mahanine can reverse an epigenetically silenced g |